Displaced Femoral Neck Fracture in Elderly Patient. Should Cement be Used for Hip Hemiarthroplasty ?
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Feb 7, 2013
Trial Information
Current as of April 27, 2025
Completed
Keywords
ClinConnect Summary
Most subcapital femoral neck fractures occur in the elderly population and are the result of low-energy trauma. Return of the patient to prefracture level of function usually can best be accomplished with surgery. Nonsurgical management has resulted in an excessive rate of medical morbidity and mortality. The overall 1-year mortality rate after hip fracture in the elderly ranges from 14% to 36%.
Prosthetic replacement has been favored for the treatment of displaced femoral neck fractures in the frail, elderly population with multiple medical comorbidities because of the challenges of achie...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • displaced femoral neck fractures (Garden III and IV)
- • 70 year old or more
- • ASA score \< or = III
- • Lee score \< or = 2
- Exclusion Criteria:
- • Parker score \<4
- • pathological femoral neck fracture ( paget disease or tumor)
About Centre Hospitalier Universitaire De Nice
The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, , France
Patients applied
Trial Officials
Regis BERNARD DE DOMPSURE, MD
Principal Investigator
University Nice Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials